With the rising tide of fatty liver disease related to metabolic dysfunction worldwide, the
association of this common liver disease with chronic kidney disease (CKD) has become …

Background Fatty liver disease in the absence of excessive alcohol consumption is an
increasingly common condition with a global prevalence of~ 25–30% and is also associated …

Vascular calcification (VC) is highly correlated with cardiovascular disease morbidity and
mortality, but anti-VC treatment remains an area to be tackled due to the ill-defined …

Background Systemic chronic inflammation plays a role in the pathophysiology of both heart
failure with preserved ejection fraction (HFpEF) and metabolic dysfunction‐associated fatty …

We aimed to compare the associations of metabolic dysfunction-associated steatotic liver
disease (MASLD) and metabolic dysfunction-associated fatty liver disease (MAFLD) with …

Background Non-alcoholic fatty liver disease (NAFLD) has emerged as a predominant driver
of chronic liver disease globally and is associated with increased cardiovascular disease …

BACKGROUND: For individuals with a coronary artery calcium (CAC) score of 0, CAC
rescans at appropriate timings are recommended, depending on individual risk profiles …

Metabolic dysfunction-associated steatotic liver disease (MASLD), previously termed
nonalcoholic fatty liver disease (NAFLD), poses a significant global health challenge due to …

Aim: We compared the association between the baseline and average lipid parameters over
time and the coronary artery calcification (CAC) risk. Methods: Participants who underwent …

Nonalcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases
worldwide. In recent years, a new terminology and definition of metabolic dysfunction …